Our Firm is representing numerous women in this litigation who allegedly suffered serious vaginal mesh complications due to products manufactured by C.R. Bard. We are pleased to see this proceeding moving forward.
New York, NY (PRWEB) June 13, 2014
Thousands of transvaginal mesh lawsuit (http://www.transvaginalmeshlawsuithelp.com/) filings pending against C.R. Bard, Inc. continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order dated June 10th, the Court has scheduled Oral Arguments on defense motions pertaining to certain discovery matters. The hearing will take place on Thursday, June 19, 2014 at 2:00 p.m. in Huntington, West Virginia. (MDL No. 2187)
“Our Firm is representing numerous women in this litigation who allegedly suffered serious vaginal mesh complications due to products manufactured by C.R. Bard. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free transvaginal mesh lawsuit consultations to women who allegedly suffered serious complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.
Transvaginal Mesh Lawsuits
Court documents indicate that more than 8,000 transvaginal mesh lawsuits are pending against C.R. Bard in the Southern District of West Virginia. All of the lawsuits allege that pelvic mesh products marketed by C.R. Bard caused plaintiffs to suffer serious vaginal mesh complications, including mesh erosion, chronic pain, and organ damage, and accuse the company of failing to provide adequate warnings about their risks. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee for the federal C.R. Bard litigation.
According to court records, more than 55,000 product liability claims have been filed in the Southern District of West Virginia on behalf of women who were allegedly harmed by transvaginal mesh. Mr. Grand is also a member of the Plaintiffs’ Steering Committees in proceedings involving American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and Ethicon, Inc. (MDL No. 2327).
Mr. Grand is also serving as Co-Liaison Counsel in two multicounty litigations underway in New Jersey Superior Court for transvaginal mesh lawsuits involving products marketed by C.R. Bard and Ethicon. He was also a member of the Plaintiff’s trial team on the first Ethicon trial in that proceeding, which ended in March 2013 with a jury awarding $11 million in compensatory and punitive damages to a woman who suffered vaginal mesh complications related to the Ethicon Gynecare Prolift device. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
Women who have allegedly suffered serious vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding vaginal mesh lawsuits can be found at Bernstein Liebhard's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To learn more please call the Firm today, at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP